NEW YORK (Reuters Health) Jul 29 –
The acetylcholinesterase inhibitor donepezil, which improves symptoms of Alzheimer’s disease, also appears to have the same beneficial effect in Down’s syndrome-associated dementia.
In a study of nine patients with Down’s syndrome with dementia, who were treated with donepezil, eight showed improvement after 5 months, compared with six matched, untreated controls, Dr. Ira T. Lott and colleagues at the University of California at Irvine report in the July issue of the Archives of Neurology.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!